{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:10:47Z","timestamp":1776409847769,"version":"3.51.2"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T00:00:00Z","timestamp":1366675200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Neurofibromatosis type 1 (NF1) is a hereditary tumor syndrome characterized by the development of benign nerve-sheath tumors, which transform to malignant peripheral nerve-sheath tumors (MPNST) in about 8 to 13% of patients with NF1. MPNST are invasive sarcomas with extremely poor prognosis, and their development may correlate with internal tumor load of patients with NF1. Because early identification of patients with NF1 at risk for developing MPNST should improve their clinical outcome, the aim of this study was to identify serum biomarkers for tumor progression in NF1, and to analyze their correlation with tumor type and internal tumor load.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We selected candidate biomarkers for NF1 by manually mining published data sources, and conducted a systematic screen of 56 candidate serum biomarkers using customized antibody arrays. Serum from 104 patients with NF1 with and without MPNST, and from 41 healthy control subjects, was analyzed. Statistical analysis was performed using the non-parametric Mann\u2013Whitney <jats:italic>U<\/jats:italic>-test, followed by Bonferroni correction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our analysis identified four markers (epidermal growth factor receptor, interferon-\u03b3, interleukin-6, and tumor necrosis factor-\u03b1) for which significantly different serum concentrations were seen in patients with NF1 compared with healthy controls. Two markers (insulin-like growth factor binding protein 1 (IGFBP1) and regulated upon activation, normal T-cell expressed and secreted (RANTES)) showed significantly higher concentrations in patients with NF1 and MPNST compared with patients with NF1 without MPNST. A correlation with internal tumor load was found for IGFBP1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study identified two serum markers with potential for early detection of patients with NF1 at risk for developing MPNST, and four markers that could distinguish between patients with NF1 and healthy subjects. Such markers may be useful as diagnostic tools to support the diagnosis of NF1 and for timely identification of MPNST. Moreover, the data suggest that there is a systemic increase in inflammatory cytokines independently of tumor load in patients with NF1.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1741-7015-11-109","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T09:33:44Z","timestamp":1366709624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors"],"prefix":"10.1186","volume":"11","author":[{"given":"Su-Jin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Sawitzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Kluwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor F","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Holtkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,23]]},"reference":[{"key":"759_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jmg.26.11.704","volume":"26","author":"SM Huson","year":"1989","unstructured":"Huson SM, Compston DA, Clark P: A genetic study of von Recklinghausen neurofibromatosis in south east Wales: I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 1989, 26: 704-711. 10.1136\/jmg.26.11.704.","journal-title":"J Med Genet"},{"key":"759_CR2","first-page":"110","volume-title":"Neurofibromatosis. Phenotype, Natural History and Pathogenesis","author":"JM Friedman","year":"1999","unstructured":"Friedman JM, Gutmann DH, Maccollin M: Neurofibromatosis. Phenotype, Natural History and Pathogenesis. 1999, Balltimore: The Johns Hopkins University Press, 110-118."},{"key":"759_CR3","volume-title":"Neurofibromatose: Cl\u00ednica, Gen\u00e9tica e Terap\u00eautica","author":"M Geller","year":"2004","unstructured":"Geller M, Bonalumi Filho A: Neurofibromatose: Cl\u00ednica, Gen\u00e9tica e Terap\u00eautica. 2004, Rio de Janeiro: Guanabara Koogan"},{"key":"759_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00234-005-0033-4","volume":"48","author":"VF Mautner","year":"2006","unstructured":"Mautner VF, Hartmann M, Kluwe L, Friedrich RE, F\u00fcnsterer C: MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1. Neuroradiology. 2006, 48: 160-165. 10.1007\/s00234-005-0033-4.","journal-title":"Neuroradiology"},{"key":"759_CR5","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","volume":"57","author":"B Ducatman","year":"1986","unstructured":"Ducatman B, Scheithauer B, Piepgras D: Malignant peripheral nerve sheath tumors: a clinicopathologic study of 120 cases. Cancer. 1986, 57: 2006-2021. 10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6.","journal-title":"Cancer"},{"key":"759_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1200\/JCO.1987.5.4.601","volume":"5","author":"C Collin","year":"1987","unstructured":"Collin C, Godbold J, Hajdu S: Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol. 1987, 5: 601-612.","journal-title":"J Clin Oncol"},{"key":"759_CR7","first-page":"1573","volume":"62","author":"RE Ferner","year":"2002","unstructured":"Ferner RE, Gutmann DH: International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res. 2002, 62: 1573-1577.","journal-title":"Cancer Res"},{"key":"759_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1212\/WNL.58.10.1461","volume":"58","author":"RJ Packer","year":"2002","unstructured":"Packer RJ, Gutmann DH, Rubenstein A, Viskochil D, Zimmerman RA, Vezina G, Small J, Korf B: Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology. 2002, 58: 1461-1470. 10.1212\/WNL.58.10.1461.","journal-title":"Neurology"},{"key":"759_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/1097-0142(19930215)71:4<1247::AID-CNCR2820710413>3.0.CO;2-S","volume":"71","author":"J Wanebo","year":"1993","unstructured":"Wanebo J, Malik J, VandenBerg S, Wanebo H, Driessen N, Persing J: Malignant peripheral nerve sheath tumors: a clinicopathological study of 28 cases. Cancer. 1993, 71: 1247-1253. 10.1002\/1097-0142(19930215)71:4<1247::AID-CNCR2820710413>3.0.CO;2-S.","journal-title":"Cancer"},{"key":"759_CR10","first-page":"2085","volume":"27","author":"RE Friedrich","year":"2007","unstructured":"Friedrich RE, Keiner D, Hagel C: Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1. Anticancer Res. 2007, 27: 2085-2090.","journal-title":"Anticancer Res"},{"key":"759_CR11","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1086\/320121","volume":"68","author":"SA Rasmussen","year":"2001","unstructured":"Rasmussen SA, Yang Q, Friedman JM: Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001, 68: 1110-1118. 10.1086\/320121.","journal-title":"Am J Hum Genet"},{"key":"759_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002, 39: 311-314. 10.1136\/jmg.39.5.311.","journal-title":"J Med Genet"},{"key":"759_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pediatrneurol.2004.11.002","volume":"32","author":"BA Ward","year":"2005","unstructured":"Ward BA, Gutmann DH: Neurofibromatosis 1: from lab bench to clinic. Pediatr Neurol. 2005, 32: 221-228. 10.1016\/j.pediatrneurol.2004.11.002.","journal-title":"Pediatr Neurol"},{"key":"759_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1046\/j.1365-2133.2002.04723.x","volume":"146","author":"B Algermissen","year":"2002","unstructured":"Algermissen B, Hermes B, Henz BM, M\u00fcller U, Berlien HP: Laser-induced weal and flare reactions: clinical aspects and pharmacological modulation. Br J Dermatol. 2002, 146: 863-868. 10.1046\/j.1365-2133.2002.04723.x.","journal-title":"Br J Dermatol"},{"key":"759_CR15","doi-asserted-by":"publisher","first-page":"e35711","DOI":"10.1371\/journal.pone.0035711","volume":"7","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF: Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One. 2012, 7: e35711-10.1371\/journal.pone.0035711.","journal-title":"PLoS One"},{"key":"759_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/088307380201700807","volume":"17","author":"A Kurtz","year":"2002","unstructured":"Kurtz A, Martuza RL: Antiangiogenesis in neurofibromatosis 1. J Child Neurol. 2002, 17: 578-584. 10.1177\/088307380201700807. discussion 602\u20134, 646\u201351","journal-title":"J Child Neurol"},{"key":"759_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0031-3025(16)34460-9","volume":"34","author":"M Lamba","year":"2002","unstructured":"Lamba M, Veinot JP, Acharya V: Vascular and valvular involvement by neurofibromatosis. Pathology. 2002, 34: 380-383.","journal-title":"Pathology"},{"key":"759_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1034\/j.1399-0004.2000.580501.x","volume":"58","author":"SJ Hamilton","year":"2000","unstructured":"Hamilton SJ, Friedman JM: Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet. 2000, 58: 341-344.","journal-title":"Clin Genet"},{"key":"759_CR19","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S0190-9622(98)70158-6","volume":"38","author":"JL Arbiser","year":"1998","unstructured":"Arbiser JL, Flynn E, Barnhill RL: Analysis of vascularity of human neurofibromas. J Am Acad Dermatol. 1998, 38: 950-954. 10.1016\/S0190-9622(98)70158-6.","journal-title":"J Am Acad Dermatol"},{"key":"759_CR20","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1158\/1078-0432.CCR-03-0769","volume":"10","author":"GA Mashour","year":"2004","unstructured":"Mashour GA, Hern\u00e1iz P, Hartmann M, Mashour S, Zhang T, Scharf B, Felderhoff-M\u00fcse U, Sakuma S, Friedrich RE, Martuza RL, Mautner VF, Kurtz A: Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1. Clin Canc Res. 2004, 10: 5677-5683. 10.1158\/1078-0432.CCR-03-0769.","journal-title":"Clin Canc Res"},{"key":"759_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1741-7015-9-82","volume":"9","author":"M Kolanczyk","year":"2011","unstructured":"Kolanczyk M, Mautner V, Kossler N, Nguyen R, K\u00fchnisch J, Zemojtel T, Jamsheer A, Wegener E, Thurisch B, Tinschert S, Holtkamp N, Park SJ, Birch P, Kendler D, Harder A, Mundlos S, Kluwe L: MIA is a potential biomarker for tumour load in neurofibromatosis type 1. BMC Med. 2011, 9: 82-10.1186\/1741-7015-9-82.","journal-title":"BMC Med"},{"key":"759_CR22","first-page":"577","volume":"22","author":"P Hau","year":"2002","unstructured":"Hau P, Apfel R, Wiese P, Tschertner I, Blesch A, Bogdahn U: Melanoma-inhibiting activity (MIA\/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin. Anticancer Res. 2002, 22: 577-583.","journal-title":"Anticancer Res"},{"key":"759_CR23","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1158\/1078-0432.CCR-10-0613","volume":"16","author":"TR Hummel","year":"2010","unstructured":"Hummel TR, Jessen WJ, Miller SJ, Kluwe L, Mautner VF, Wallace MR, L\u00e1zaro C, Page GP, Worley PF, Aronow BJ, Schorry EK, Ratner N: Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin. Clin Cancer Res. 2010, 16: 5048-5057. 10.1158\/1078-0432.CCR-10-0613.","journal-title":"Clin Cancer Res"},{"key":"759_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-pathol-011811-132441","volume":"7","author":"K Staser","year":"2012","unstructured":"Staser K, Yang FC, Clapp DW: Pathogenesis of plexiform neurofibroma: tumor-stromal\/hematopoietic interactions in tumor progression. Annu Rev Pathol. 2012, 7: 469-495. 10.1146\/annurev-pathol-011811-132441.","journal-title":"Annu Rev Pathol"},{"key":"759_CR25","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1038\/sj.onc.1210261","volume":"26","author":"LQ Le","year":"2007","unstructured":"Le LQ, Parada LF: Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene. 2007, 26: 4609-4616. 10.1038\/sj.onc.1210261.","journal-title":"Oncogene"},{"key":"759_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brainresbull.2011.08.005","volume":"88","author":"NM Brossier","year":"2012","unstructured":"Brossier NM, Carroll SL: Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system. Brain Res Bull. 2012, 88: 58-71. 10.1016\/j.brainresbull.2011.08.005.","journal-title":"Brain Res Bull"},{"key":"759_CR27","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1172\/JCI19195","volume":"112","author":"FC Yang","year":"2003","unstructured":"Yang FC, Ingram DA, Chen S, Hingtgen CM, Ratner N, Monk KR, Clegg T, White H, Mead L, Wenning MJ, Williams DA, Kapur R, Atkinson SJ, Clapp DW: Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+\/\u2212 mast cells. J Clin Invest. 2003, 112: 1851-1861.","journal-title":"J Clin Invest"},{"key":"759_CR28","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1093\/hmg\/ddl165","volume":"15","author":"FC Yang","year":"2006","unstructured":"Yang FC, Chen S, Clegg T, Li X, Morgan T, Estwick SA, Yuan J, Khalaf W, Burgin S, Travers J, Parada LF, Ingram DA, Clapp DW: Nf1+\/\u2212 mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Hum Mol Genet. 2006, 15: 2421-2437. 10.1093\/hmg\/ddl165.","journal-title":"Hum Mol Genet"},{"key":"759_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.it.2004.02.013","volume":"25","author":"TC Theoharides","year":"2004","unstructured":"Theoharides TC, Conti P: Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 2004, 25: 235-241. 10.1016\/j.it.2004.02.013.","journal-title":"Trends Immunol"},{"key":"759_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","volume":"135","author":"FC Yang","year":"2008","unstructured":"Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, Li X, Yang X, Knowles S, Horn W, Li Y, Zhang S, Yang Y, Vakili ST, Yu M, Burns D, Robertson K, Hutchins G, Parada LF, Clapp DW: Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2212 and c-kit-dependent bone marrow. Cell. 2008, 135: 437-448. 10.1016\/j.cell.2008.08.041.","journal-title":"Cell"},{"key":"759_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A: Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007, 44: 81-88. 10.1136\/jmg.2007.049122.","journal-title":"J Med Genet"},{"key":"759_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000, 25: 25-29. 10.1038\/75556.","journal-title":"Nat Genet"},{"key":"759_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0168-9525(97)01103-7","volume":"13","author":"M Rebhan","year":"1997","unstructured":"Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D: GeneCards: integrating information about genes, proteins and diseases. Trends Genet. 1997, 13: 163-10.1016\/S0168-9525(97)01103-7.","journal-title":"Trends Genet"},{"key":"759_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2340\/00015555-0938","volume":"90","author":"Y Yoshida","year":"2010","unstructured":"Yoshida Y, Adachi K, Yamamoto O: Local mast cell histamine and plasma histamine levels in neurofibromatosis type 1. Acta Derm Venereol. 2010, 90: 637-639. 10.2340\/00015555-0938.","journal-title":"Acta Derm Venereol"},{"key":"759_CR35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI41443","volume":"120","author":"EA Lasater","year":"2010","unstructured":"Lasater EA, Li F, Bessler WK, Estes ML, Vemula S, Hingtgen CM, Dinauer MC, Kapur R, Conway SJ, Ingram DA: Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans. J Clin Invest. 2010, 120: 859-870. 10.1172\/JCI41443.","journal-title":"J Clin Invest"},{"key":"759_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1479-5876-9-113","volume":"9","author":"HO Kim","year":"2011","unstructured":"Kim HO, Kim HS, Youn JC, Shin EC, Park S: Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays. J Transl Med. 2011, 9: 113-10.1186\/1479-5876-9-113.","journal-title":"J Transl Med"},{"key":"759_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.exger.2004.01.009","volume":"39","author":"KS Krabbe","year":"2004","unstructured":"Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp Gerontol. 2004, 39: 687-699. 10.1016\/j.exger.2004.01.009.","journal-title":"Exp Gerontol"},{"key":"759_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2011.11.022","volume":"327","author":"S Nowsheen","year":"2012","unstructured":"Nowsheen S, Aziz K, Panayiotidis MI, Georgakilas AG: Molecular markers for cancer prognosis and treatment: Have we struck gold?. Cancer Lett. 2012, 327: 142-152. 10.1016\/j.canlet.2011.11.022.","journal-title":"Cancer Lett"},{"key":"759_CR39","doi-asserted-by":"publisher","first-page":"565187","DOI":"10.1155\/2011\/565187","volume":"2011","author":"M Baay","year":"2011","unstructured":"Baay M, Brouwer A, Pauwels P, Peeters M, Lardon F: Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol. 2011, 2011: 565187.","journal-title":"Clin Dev Immunol"},{"key":"759_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/347669a0","volume":"347","author":"TJ Schall","year":"1990","unstructured":"Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990, 347: 669-671. 10.1038\/347669a0.","journal-title":"Nature"},{"key":"759_CR41","first-page":"4681","volume":"59","author":"G Luboshits","year":"1999","unstructured":"Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I, Ben-Baruch A: Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res. 1999, 59: 4681-4687.","journal-title":"Cancer Res"},{"key":"759_CR42","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/er.18.6.801","volume":"18","author":"S Rajaram","year":"1997","unstructured":"Rajaram S, Baylink DJ, Mohan S: Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 1997, 18: 801-831. 10.1210\/er.18.6.801.","journal-title":"Endocr Rev"},{"key":"759_CR43","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1055\/s-2004-814147","volume":"35","author":"E Giovannucci","year":"2003","unstructured":"Giovannucci E: Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res. 2003, 35: 694-704.","journal-title":"Horm Metab Res"},{"key":"759_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1200\/JCO.2008.17.9945","volume":"27","author":"BM Wolpin","year":"2009","unstructured":"Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL, Fuchs CS: Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2009, 27: 176-185. 10.1200\/JCO.2008.17.9945.","journal-title":"J Clin Oncol"},{"key":"759_CR45","first-page":"1013","volume":"5","author":"TT Tran","year":"1996","unstructured":"Tran TT, Medline A, Bruce WR: Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev. 1996, 5: 1013-1015.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"759_CR46","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/jcp.56.10.758","volume":"56","author":"KS Cunha","year":"2003","unstructured":"Cunha KS, Barboza EP, Da Fonseca EC: Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1. J Clin Pathol. 2003, 56: 758-763. 10.1136\/jcp.56.10.758. J Neurooncol 2011; 102:71\u201380","journal-title":"J Clin Pathol"},{"key":"759_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/stem.1215","volume":"31","author":"M Rodrigues","year":"2013","unstructured":"Rodrigues M, Blair H, Stockdale L, Griffith L, Wells A: Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from fasl induced apoptosis. Stem Cells. 2013, 31: 104-116. 10.1002\/stem.1215.","journal-title":"Stem Cells"},{"key":"759_CR48","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.stem.2008.10.003","volume":"3","author":"JP Williams","year":"2008","unstructured":"Williams JP, Wu J, Johansson G, Rizvi TA, Miller SC, Geiger H, Malik P, Li W, Mukouyama YS, Cancelas JA, Ratner N: Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential. Cell Stem Cell. 2008, 3: 658-669. 10.1016\/j.stem.2008.10.003.","journal-title":"Cell Stem Cell"},{"key":"759_CR49","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jcp.2004.023598","volume":"59","author":"K Karube","year":"2006","unstructured":"Karube K, Nabeshima K, Ishiguro M, Harada M, Iwasaki H: cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours. J Clin Pathol. 2006, 59: 160-165. 10.1136\/jcp.2004.023598.","journal-title":"J Clin Pathol"},{"key":"759_CR50","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s11064-007-9279-z","volume":"32","author":"SL Thomas","year":"2007","unstructured":"Thomas SL, De Vries GH: Angiogenic expression profile of normal and neurofibromin-deficient human Schwann cells. Neurochem Res. 2007, 32: 1129-1141. 10.1007\/s11064-007-9279-z.","journal-title":"Neurochem Res"},{"key":"759_CR51","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1128\/MCB.23.6.2213-2224.2003","volume":"23","author":"SJ Miller","year":"2003","unstructured":"Miller SJ, Li H, Rizvi TA, Huang Y, Johansson G, Bowersock J, Sidani A, Vitullo J, Vogel K, Parysek LM, DeClue JE, Ratner N: Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mol Cell Biol. 2003, 23: 2213-2224. 10.1128\/MCB.23.6.2213-2224.2003.","journal-title":"Mol Cell Biol"},{"key":"759_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1017\/S1740925X04000274","volume":"1","author":"PR Lee","year":"2004","unstructured":"Lee PR, Cohen JE, Tendi EA, Farrer R, DE Vries GH, Becker KG, Fields RD: Transcriptional profiling in an MPNST-derived cell line and normal human Schwann cells. Neuron Glia Biol. 2004, 1: 135-147. 10.1017\/S1740925X04000274.","journal-title":"Neuron Glia Biol"},{"key":"759_CR53","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jmg.38.9.638","volume":"38","author":"M Bahuau","year":"2001","unstructured":"Bahuau M, Pelet A, Vidaud D, Lamireau T, LeBail B, Munnich A, Vidaud M, Lyonnet S, Lacombe D: GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype. J Med Genet. 2001, 38: 638-643. 10.1136\/jmg.38.9.638.","journal-title":"J Med Genet"},{"key":"759_CR54","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1158\/1078-0432.CCR-03-0712","volume":"10","author":"P L\u00e9vy","year":"2004","unstructured":"L\u00e9vy P, Bi\u00e8che I, Leroy K, Parfait B, Wechsler J, Laurendeau I, Wolkenstein P, Vidaud M, Vidaud D: Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Clin Cancer Res. 2004, 10: 3763-3771. 10.1158\/1078-0432.CCR-03-0712.","journal-title":"Clin Cancer Res"},{"key":"759_CR55","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1346-8138.2002.tb00180.x","volume":"29","author":"J Nakayama","year":"2002","unstructured":"Nakayama J, Terao H: Gamma interferon directly inhibits the growth of neurofibroma cells in vitro. J Dermatol. 2002, 29: 556-561.","journal-title":"J Dermatol"},{"key":"759_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physiolgenomics.00066.2003","volume":"16","author":"EP Tierney","year":"2003","unstructured":"Tierney EP, Tulac S, Huang ST, Giudice LC: Activation of the protein kinase A pathway in human endometrial stromal cells reveals sequential categorical gene regulation. Physiol Genomics. 2003, 16: 47-66. 10.1152\/physiolgenomics.00066.2003.","journal-title":"Physiol Genomics"},{"key":"759_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4161\/epi.3.1.5469","volume":"3","author":"RG Tuskan","year":"2008","unstructured":"Tuskan RG, Tsang S, Sun Z, Baer J, Rozenblum E, Wu X, Munroe DJ, Reilly KM: Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels. Epigenetics. 2008, 3: 43-50. 10.4161\/epi.3.1.5469.","journal-title":"Epigenetics"},{"key":"759_CR58","first-page":"79","volume":"303","author":"JI Park","year":"2005","unstructured":"Park JI, Powers JF, Tischler AS, Strock CJ, Ball DW, Nelkin BD: GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK\/ERK pathway in pheochromocytoma cells derived from nf1-heterozygous knockout mice. Exp Cell Res. 2005, 303: 79-88.","journal-title":"Exp Cell Res"},{"key":"759_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF00133486","volume":"13","author":"D Muir","year":"1995","unstructured":"Muir D: Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin Exp Metastasis. 1995, 13: 303-314. 10.1007\/BF00133486.","journal-title":"Clin Exp Metastasis"},{"key":"759_CR60","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/1078-0432.CCR-06-0182","volume":"13","author":"P L\u00e9vy","year":"2007","unstructured":"L\u00e9vy P, Ripoche H, Laurendeau I, Lazar V, Ortonne N, Parfait B, Leroy K, Wechsler J, Salmon I, Wolkenstein P, Dessen P, Vidaud M, Vidaud D, Bi\u00e8che I: Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin Cancer Res. 2007, 13: 398-407. 10.1158\/1078-0432.CCR-06-0182.","journal-title":"Clin Cancer Res"},{"key":"759_CR61","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.prp.2008.01.013","volume":"204","author":"A Terzi","year":"2008","unstructured":"Terzi A, Saglam EA, Barak A, Soylemezoglu F: The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays. Pathol Res Pract. 2008, 204: 305-314. 10.1016\/j.prp.2008.01.013.","journal-title":"Pathol Res Pract"},{"key":"759_CR62","unstructured":"Cancer Genome Anatomy Project. http:\/\/cgap.nci.nih.gov\/cgci.html."},{"key":"759_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30: 207-210. 10.1093\/nar\/30.1.207.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-11-109\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:52:22Z","timestamp":1630540342000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-11-109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,23]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-11-109","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,23]]},"assertion":[{"value":"27 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"109"}}